Tomorrow is Neuroendocrine Tumours (NETs) Awareness Day – November 10th. At Curium, we’re committed to advancing nuclear medicine to improve lives, and raising awareness of NETs is a key part of our mission. These rare tumours often go undiagnosed, underscoring the need for awareness, early diagnosis, and increased research. Thank you to Ilka Peters, a NETs patient, and Shane Peters, her caregiver, for helping to shine a light on this important cause. Watch their video to learn how each of us can make a difference. Learn more and join the NETs community here: https://lnkd.in/ei5dH3R #CuriumCare #NETCancerDay #NeuroendocrineTumors #PatientCare #LetsTalkAboutNETs
Curium Pharma
Geneesmiddelenproductie
Paris, France 38.955 volgers
De ervaring van kanker opnieuw definiëren door onze jarenlange ervaring in de nucleaire geneeskunde
Over ons
Curium is wereldwijd marktleider in nucleaire geneeskunde en levert levensveranderende diagnostiek en behandeling aan patiënten over de hele wereld. We ontwikkelen, produceren en distribueren radiofarmaceutische producten van wereldklasse met een hernieuwde focus op kanker, waarbij we onontgonnen potentieel voor nieuwe innovatie onderzoeken. We bouwen voort op opmerkelijke fundamenten en een nalatenschap van het leveren van betrouwbare en consistente nucleaire oplossingen aan tienduizenden patiënten per dag. Ons bewezen erfgoed in combinatie met een baanbrekende aanpak zijn de kenmerken van waaruit we levensveranderende diagnostiek en therapeutica leveren. Onze mensen staan aan de basis van de enorme impact die ze hebben. Als onderdeel van onze visie voor 2030 om een leider te worden in oncologische nucleaire geneeskunde - zowel op het gebied van diagnostiek als therapie - zullen we ons bereik verder uitbreiden naar Japan en China, waarbij we onze superieure producten blijven uitrollen naar een wereldwijde markt. De impact van deze investeringen op patiënten zal levensveranderend zijn. Onze focus op kanker ligt momenteel op neuro-endocriene tumoren (NET's) en prostaatkanker PSMA. We werken ook aan het benutten van de kracht van AI om de beeldkwaliteit en -nauwkeurigheid te verbeteren; om patronen te identificeren die helpen bij het diagnosticeren van pathologieën en natuurlijk om artsen beter te ondersteunen. Onze belofte We streven ernaar het onmogelijke mogelijk te maken en een organisatie te zijn die het gezicht van de geneeskunde zal veranderen. Onze diverse groep van industrie-experts is verenigd onder één sterke en enkelvoudige focus - het ontwikkelen, produceren en leveren van revolutionaire diagnostische en therapeutische radiofarmaceutica aan onze klanten over de hele wereld met ongeëvenaarde betrouwbaarheid en superieure service.
- Website
-
http://curiumpharma.com/
Externe link voor Curium Pharma
- Branche
- Geneesmiddelenproductie
- Bedrijfsgrootte
- 1.001 - 5.000 medewerkers
- Hoofdkantoor
- Paris, France
- Type
- Particuliere onderneming
- Opgericht
- 2017
- Specialismen
- Nuclear Medicine, PET Imaging, Molecular Imaging, cGMP Manufacturing , Contract Manufacturing en SPECT Imaging
Locaties
Medewerkers van Curium Pharma
-
Adolfo D'Erizans
Principal Project Manager & Motorsports Enthusiast
-
Edouard Wang
Vice President Sales & Marketing Europe - Curium Pharma
-
Luc Leroy
Resourceful, resilient, and innovative strategic IT Director, with proven experience in managing global IT enterprise transformations, business…
-
Nikhil da Costa
Group PMO Director at Curium Pharma
Updates
-
Movember: Raising Awareness for Prostate Cancer Prostate cancer impacts 1 in 11 men in Europe (1), and early detection is crucial. For over 60 years, Curium has been pioneering nuclear medicine solutions to redefine cancer care and enhance patients' lives. Key symptoms of prostate cancer can include: • Blood in urine or semen • Frequent or painful urination • Sudden erectile dysfunction • Bone pain Since symptoms may not appear in early stages, regular screenings are crucial – especially for men over 50. At Curium, we are dedicated on redefining the experience of cancer worldwide. Join us and learn more this Movember about men’s health and prostate cancer awareness: https://www.movember.com (1) https://lnkd.in/d6P3jyZU
Deze content is hier niet beschikbaar
Open deze content en meer in de LinkedIn-app
-
At Curium, we harness the power of nuclear medicine to improve people’s lives. Learn about our purpose and our commitment to the Neuroendocrine tumors (NETs) community over the past 30 years. https://lnkd.in/dTFZzWNm #NETCancerDay #NeuroendocrineTumors #LetsTalkAboutNETs #30yearsinNETs
-
Did you know? Neuroendocrine tumours (NETs) often go misdiagnosed due to varying symptoms. At Curium, we’re committed to changing that, with a team of dedicated professionals advancing targeted diagnostics and therapies to empower patients with earlier detection and personalized treatment options. Jennifer Yessaian RN, MBA, Senior Director of Marketing shares her thoughts on the importance of early detection and how continued research and innovation are crucial for NETs patients. On November 10, we unite with patients, families, and healthcare providers to raise awareness for NETs and reinforce our mission to improve patient outcomes. Let’s bring visibility to this rare disease and drive meaningful progress together. Learn more and join the NETs community here: https://lnkd.in/ei5dH3R #CuriumCare #NETCancerDay #NeuroendocrineTumors #PatientCare #LetsTalkAboutNETs
-
Today marks the start of Movember! Since 2003, Movember has supported over 1,250 mens health projects globally, focusing on mental health, suicide prevention, prostate cancer, and testicular cancer. At Curium, we proudly stand with this movement, raising awareness and supporting the fight against prostate cancer. Will you join us in growing a mo' this Movember? Every conversation and contribution counts in helping to change the face of men’s health. Learn how you can get involved in the activities at Movember’s website! movember.com #Movember #MensHealth #ProstateCancer #GrowAMo
-
Meet Sven Ockers, a passionate Professional Services Specialist at Curium Petten. His journey into radiopharmaceuticals began when his wife’s treatment for Graves' disease sparked his curiosity, leading to a rewarding career at Curium. Sven values Curium’s collaborative spirit and open-minded leadership, saying, “Our teamwork enables us to consistently help customers and distributors.” He’s also proud of Curium's commitment to community, from supporting local charities to volunteering for events like “Opkikker dag” for sick children. Want to make a difference? Explore career opportunities at Curium! https://lnkd.in/dtfW5yZR #Curium #EmployeeSpotlight #Innovation #NuclearMedicine #Healthcare #Teamwork #CareerGrowth
-
Today we wrapped up an amazing #EANM24! It was great to showcase Curium’s latest advancements in nuclear medicine and our commitment to transforming nuclear medicine. As the industry advances, we’re empowering clinicians with innovative AI and imaging tools for earlier cancer detection and more accurate diagnoses. A big thank you to everyone who visited our booth and attended our symposium! See you next year in Barcelona! https://lnkd.in/d8BBsq3a #EANM24 #radiopharmaceuticals #nuclearmedicine #molecularimaging #clinicaltrials #prostatecancer #oncology #NucMed #urology #PSMA #PET #AI
-
Day 2 at #EANM24 – Join us at Booth #H14! At EANM we’re showcasing Curium’s advancements in nuclear medicine as we transform diagnostic accuracy and patient care. Here’s what to expect at our booth: - Live Demos: Get hands-on with PYLCLARI AI and PIUR – two technologies that are redefining the future of healthcare. - Expert Insights: Engage with our team of specialists to learn how Curium is pioneering the future of nuclear medicine. Take this opportunity to explore innovations that are shaping the industry. Come meet us at Booth #H14 in Hamburg! https://lnkd.in/dabiy3c8 #EANM24 #radiopharmaceuticals #nuclearmedicine #molecularimaging #clinicaltrials #prostatecancer #oncology #NucMed #urology #PSMA #PET #AI
-
Join us tomorrow at #EANM24 for the symposium on how PSMA PET is transforming prostate cancer care. With insights from experts Prof. Dr. Jochen Christoph Walz, Prof. Dr. Harun Ilhan, and Prof. Dr. Gary Cook (MBBS MSc MD FRCR FRCP), we’ll dive into the real-world impact of this technology and its potential to revolutionize nuclear medicine and urology. Don’t miss out!I - Date: Monday, 21st October - Time: 13:15-14:45 CET - Location: Hamburg, Hall Y10-Y12 Register here: https://lnkd.in/dwkRWM4q
-
𝐎𝐧𝐥𝐲 1 𝐃𝐚𝐲 𝐭𝐨 𝐆𝐨 𝐔𝐧𝐭𝐢𝐥 #EANM24! The Curium team is already in Hamburg getting ready for the European Association of Nuclear Medicine (EANM) Congress. We invite you to visit us at booth #H14, where you can meet our team and learn about the latest developments in nuclear medicine. Whether you're interested in new technologies or industry trends, we look forward to discussing how Curium is contributing to the future of healthcare. We hope to see you there! https://lnkd.in/dabiy3c8 #EANM24 #radiopharmaceuticals #nuclearmedicine #molecularimaging #clinicaltrials #prostatecancer #oncology #NucMed #urology #PSMA #PET #AI